AKT1 and colorectal cancer: The administration of AP or P or AP + P as therapy or prophylaxis in PHZ-induced colorectal cancer significantly downregulated the colonic mRNA expression of PI3K, AKT, c-Myc, CK-20, SOX-2, OCT-4, and NanoG compared to the PHZ group.